Alpha Tau Medical Ltd.
NASDAQ:DRTS
Overview | Financials
Company Name | Alpha Tau Medical Ltd. |
Symbol | DRTS |
Currency | USD |
Price | 3.1 |
Market Cap | 216,765,020 |
Dividend Yield | 0% |
52-week-range | 1.75 - 3.4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Uzi Sofer |
Website | https://www.alphatau.com |
An error occurred while fetching data.
About Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD